Kymera Therapeutics, Inc. (KYMR)

Last Three Months

27-Jan-24 -- 26-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

2

(1)

8

0

4

+1

0

+2

0

+3

Two Year Chart

27-Apr-22 -- 26-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
21-Feb-24 6:46 PM View:	21-Feb-24 Planned Option Sale ($171.23K)	Albers Jeffrey W. Director		Kymera Therapeutics, Inc. - KYMR	0% --	0	0	--	--	Show Txns Hide Txns

04-Mar-24 6:12 PM View:	04-Mar-24 Sale ($164.66K)	Jacobs Bruce N. Chief Financial Officer		Kymera Therapeutics, Inc. - KYMR	24% 115.03K to 142.35K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 6:21 PM View:	04-Mar-24 Sale ($139.97K)	Gollob Jared Chief Medical Officer		Kymera Therapeutics, Inc. - KYMR	28% 74.71K to 95.74K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 7:23 PM View:	15-Mar-24 Sale (Planned) ($2.90M)	Booth Bruce Director		Kymera Therapeutics, Inc. - KYMR	(8%) 5.86M to 5.38M	0	0	--	--	Show Txns Hide Txns

13-Mar-24 7:53 PM View:	13-Mar-24 Sale (Planned) ($1.02M)	Atlas Venture Fund X, L.P. 10% Owner		Kymera Therapeutics, Inc. - KYMR	(6%) 5.86M to 5.5M	0	0	--	--	Show Txns Hide Txns

04-Mar-24 6:15 PM View:	01-Mar-24 Grant 0	Chiniara Ellen Chief Legal Officer		Kymera Therapeutics, Inc. - KYMR	64% 34.2K to 55.96K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 6:16 PM View:	01-Mar-24 Grant 0	Chadwick Jeremy G Chief Operating Officer		Kymera Therapeutics, Inc. - KYMR	40% 33.33K to 46.76K	0	0	--	--	Show Txns Hide Txns